However, simple binary resistance assays were hard to interpret because FM phenotypes obscured phage plaque formation (turbid plaques). We therefore performed growth rate assays in the presence of ...

The US Patent No. 13/627,060: “Recombinant Phage and Methods” contributes to Sample6’s process for phage engineering. They found that phage genomes are not lethal in yeast cells and phage can be ...

The ability of the MS2 plaque reduction assay to detect antiviral activity in these known antiviral plant preparations indicates its suitability as an antiviral screening tool.

Bacteriophages, or phages, viruses that selectively target and infect bacteria, have drawn growing attention for their potential use in a host of biotechnological processes to benefit humankind, from ...